Celldex Therapeutics, Inc. is 1.1x more valuable than NEOGEN CORP by market capitalization ($2.30 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CLDX | NEOG |
|---|---|---|
| Market cap | $2.30 B | $2.01 B |
| US-listed rank | #1997 | #2096 |
| Revenue (latest FY) | $1.54M | $894.66M |
| Net income (latest FY) | -$258.76M | -$1.09B |
| Net margin | -16748.0% | -122.1% |
| SEC filings | 1,268 | 1,896 |
Celldex Therapeutics, Inc. is 1.1x more valuable than NEOGEN CORP by market capitalization ($2.30 B vs $2.01 B).
In their latest fiscal years, Celldex Therapeutics, Inc. reported $1.54M in revenue while NEOGEN CORP reported $894.66M.
Full pages: Celldex Therapeutics, Inc. and NEOGEN CORP, or browse the full rankings.